Duke Cancer Center — Durham, North Carolina

Duke Cancer Center is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke Cancer Center has participated in 109 clinical trials with 48 currently active.

Therapeutic areas: Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).

Sponsors: Phanes Therapeutics, Duke University, Amgen.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center?

Duke Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center conducted?

Duke Cancer Center has 109 clinical trials on record, with 48 currently active. Their work covers Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC).

Is Duke Cancer Center accredited by Crixeo Health?

Yes — Duke Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.